Annovis Bio, Inc. (ANVS) Form 424B5 — May 20, 2026
Annovis Bio (ANVS) is launching a registered public offering of 7,895,000 shares of common stock and accompanying warrants at a combined price of $1.90 per unit, raising approximately $15.0 million in gross proceeds. The company stated it does not have sufficient capital to fund operations for the next 12 months and will need to raise additional capital to meet obligations, citing a going-concern warning in its recent 10-K.
Key figures
- Net Proceeds
- 13800000
- Cash Position
- 14200000
- Gross Proceeds
- 15000500
- Offering Price
- 1.9
- Shares Offered
- 7895000
- Warrants Offered
- 7105500
- Shares Outstanding
- 34646868
- Warrant Exercise Price
- 2.25
- Shares Outstanding Post Offering
- 42541868
- Atm Facility Remaining
- 39284786
- Recent Direct Offering Price
- 1.9
- Recent Direct Offering Shares
- 5263156
- Dilution Per Share New Investors
- 1.24
- Net Tangible Book Value Per Share
- 0.11
- Recent Direct Offering Proceeds
- 9300000
- Adjusted Net Tangible Book Value Per Share
- 0.66
- Recent Direct Offering Warrant Exercise Price
- 2.5
Price after filing
1 day: +5.4%7 days: -1.5%30 days: -14.2%
Close on the filing date to close N calendar days later (from $2.04). Historical, not a forecast.
AI analysis
Red flags5 · Pro
The rest of the AI analysis, red flags and sentiment are part of Signal8 Pro.
AI-generated analysis of a public disclosure. Not investment advice; verify against the original document.